Cetera Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.7M Buy
39,147
+32,821
+519% +$2.08M 0.02% 685
2023
Q4
$468K Buy
6,326
+22
+0.3% +$1.44K 0.01% 1165
2023
Q3
$430K Buy
6,304
+1,607
+34% +$136K 0.01% 1145
2023
Q2
$441K Sell
4,697
-752
-14% -$58.7K 0.01% 1125
2023
Q1
$369K Sell
5,449
-1,042
-16% -$67K 0.01% 1176
2022
Q4
$321K Buy
+6,491
New +$265K 0.01% 1195
2022
Q1
Sell
-8,183
Closed -$637K 1448
2021
Q4
$637K Sell
8,183
-159
-2% -$14K 0.01% 787
2021
Q3
$796K Buy
8,342
+5,781
+226% +$610K 0.02% 692
2021
Q2
$318K Buy
+2,561
New +$306K 0.01% 1025
2020
Q4
Sell
-6,579
Closed -$671K 1044
2020
Q3
$671K Buy
6,579
+2,829
+75% +$244K 0.03% 467
2020
Q2
$326K Sell
3,750
-1,783
-32% -$142K 0.01% 679
2020
Q1
$321K Buy
5,533
+2,498
+82% +$203K 0.02% 576
2019
Q4
$277K Buy
+3,035
New +$267K 0.01% 742

Other funds holding EXAS

Cetera Advisors's EXAS Position: Q1 2024 in Review

Cetera Advisors increased its Exact Sciences (EXAS) stake by 519% in Q1 2024, buying an estimated $2.08M and bringing the position to 39,147 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #685.

Cetera Advisors first reported a position in EXAS in Q4 2019 and has held it in 13 quarters since. 625 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

  • Cetera Advisors held 39,147 shares of Exact Sciences worth $2.7M as of Q1 2024.
  • Cetera Advisors bought 32,821 Exact Sciences shares in Q1 2024, an estimated $2.08M.
  • Exact Sciences made up 0.02% of Cetera Advisors's portfolio in Q1 2024, its #685 holding.
  • Cetera Advisors first reported a position in Exact Sciences in Q4 2019 and has held it in 13 quarters since.
  • 625 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.